SCHEMBL6989347

SCHEMBL6989347

CC(C)(C)OC(=O)NCCOc1noc2ccc(F)c(C(N)=O)c12

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CA12 O43570 5/20 0.42
CA1 P00915 5/20 0.42
CA2 P00918 5/20 0.42
CA9 Q16790 5/20 0.42
IDO1 P14902 4/20 0.40
SCN9A Q15858 1/20 0.40
PDK2 Q15119 1/20 0.36
CYP1A1 P04798 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2B6 P20813 1/20 0.36
CYP2C19 P33261 1/20 0.36
CYP3A43 Q9HB55 1/20 0.36
BCHE P06276 1/20 0.33
CNR2 P34972 1/20 0.33
ATR Q13535 1/20 0.33
SIRT2 Q8IXJ6 1/20 0.33
SIRT1 Q96EB6 1/20 0.33
SIRT3 Q9NTG7 1/20 0.33
DRD2 P14416 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6991888 0.91 CA12 (0.40) CA12CA1CA2CA9IDO1
SCHEMBL6988146 0.90 CA12 (0.40) CA12CA1CA2CA9IDO1
SCHEMBL6994606 0.87 CA12 (0.42) CA12CA1CA2CA9IDO1
SCHEMBL6986596 0.84 IDO1 (0.42) CA12CA1CA2CA9IDO1
SCHEMBL6988434 0.83 SCN9A (0.48) CA12CA1CA2CA9IDO1
SCHEMBL6986569 0.83 IDO1 (0.39) CA12CA1CA2CA9IDO1
SCHEMBL6989405 0.82 CA1 (0.47) CA12CA1CA2CA9IDO1
SCHEMBL8200678 0.81 IDO1 (0.49) IDO1
SCHEMBL6992284 0.81 CA12 (0.44) CA12CA1CA2CA9IDO1
SCHEMBL6991153 0.80 IDO1 (0.33) IDO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0779281-B1 ISOXAZOLES SANKYO CO (JP) 2003-10-29 EP disclosed
US-6096771-A ISOXAZOLE DERIVATIVES EXHIBITING EXCELLENT TYPE B AND TYPE A MONOAMINE OXIDASE INHIBITORY ACTIVITIES, THEREFORE USEFUL FOR PREVENTING PARKINSON'S DISEASE, DEPRESSION AND ALZHEIMER'S DISEASE SANKYO COMPANY, LIMITED (JP) 2000-08-01 US disclosed
US-5965591-A MONOAMINE OXIDASE INHIBITOR; FOR PROPHYLAXIS AND TREATING PARKINSON'S DISEASE, DEPRESSION AND ALZHEIMER'S DISEASE SANKYO COMPANY, LIMITED (JP) 1999-10-12 US disclosed
EP-0779281-A1 ISOXAZOLES SANKYO COMPANY LIMITED (JP) 1997-06-18 EP disclosed